The needs of people who menstruate, particularly women, have been routinely ignored and deprioritised by prison and state systems during the pandemic emergency.

The EU Civil Society Forum on Drugs lays out guidelines on how to make the involvement of civil society in drug policy more meaningful.

The 1st Brandenburg Forum was held to facilitate openness and to build upon the series of high-profile Brandenburg Forums on Drugs and Development Policies held in Germany since 2016.

IDPC highlights several systemic issues prevalent in human rights abuses directed at those held against their will in drug treatment centres.

Hill, Fehér, and Bridge outline civil society engagement processes and encourage practitioners to take a more active role.

FEDITO BLX and IDPC make recommendations for Belgium's UPR, focusing on adopting a public health approach, decriminalising people who use drugs and providing a clear legal framework for drug consumption rooms.

IDPC provides a critique of the UNODC Strategy 2021-2025 with a focus on two critical issues: the exclusion of civil society and communities from the development and approval of the document; and the departure from the policy priorities established in the 2018 UN system Common Position on drugs.

IDPC takes stock of progress made on the implementation of the recommendations included in the UNGASS Outcome Document, focusing on six critical areas: public health, development, human rights, civil society engagement, UN agency collaboration and cooperation, and drug policy evaluation.

IDPC and TNI provide an overview of the evolution of the UN-agreed language on key drug policy issues for the last three decades.

Based on experiences from dozens of countries across the globe, IDPC outlines key lessons learned from civil society advocacy during and after the COVID-19 pandemic.

IDPC explores national prison decongestion policies during the ongoing COVID-19 pandemic, highlighting opportunities, challenges and lessons learnt.

IDPC reviews developments in relation to incarceration and drug policy in Cambodia, especially in light of the COVID-19 pandemic, and their specific impacts on women and children.

IDPC and GDPO acknowledge the wealth of data in the World Drug Report, whilst critiquing its overly positive outlook on the impact of drug control efforts and law enforcement approaches.

Ten years after the adoption of the Bangkok Rules, countries have largely failed to implement them, while the number of women in prison has risen dramatically.

The Support. Don’t Punish campaign documents global efforts to progress harm reduction and drug policy reform as part of the 2020 Global Day of Action.

HRI and IDPC discuss some of the current and emerging challenges specifically faced by people detained for drug offences and people in detention who use drugs.

Conectas, IDPC, and INNPD provide input to the Committee on Economic, Social and Cultural Rights focusing on the serious violation of the rights to health of people who use drugs in Brazil.

IDPC and a coalition of NGOs provide recommendations to ensure that Nepalese national drug policies respect human rights and fundamental freedoms.

Despite substantial, and welcomed, changes in the INCB's approach to human rights, reticences remain and point to structural conflicts between drug policy and human rights within the UN system.

IDPC, WOLA and PRI note an alarming rise in female incarceration rates in Latin America since 2000, putting countless women at risk of abuse and exacerbating the vulnerabilities they face in society.